(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -8.21%4.89B | -1.23%9.99B | 7.01%5.33B | 6.59%10.11B | 3.80%4.98B | 6.31%9.49B | 9.38%4.8B | -1.01%8.92B | 0.21%4.38B | -4.75%9.01B |
Operating income | -8.21%4.89B | -1.23%9.99B | 7.01%5.33B | 6.59%10.11B | 3.80%4.98B | 6.31%9.49B | 9.38%4.8B | -1.01%8.92B | 0.21%4.38B | -4.75%9.01B |
Cost of sales | -1.35%-3.08B | -0.17%-5.79B | -6.82%-3.04B | -5.79%-5.78B | -1.43%-2.84B | -8.31%-5.46B | -14.88%-2.8B | -1.59%-5.04B | -2.26%-2.44B | 11.15%-4.96B |
Operating expenses | -1.35%-3.08B | -0.17%-5.79B | -6.82%-3.04B | -5.79%-5.78B | -1.43%-2.84B | -8.31%-5.46B | -14.88%-2.8B | -1.59%-5.04B | -2.26%-2.44B | 11.15%-4.96B |
Gross profit | -20.88%1.81B | -3.09%4.2B | 7.26%2.29B | 7.67%4.34B | 7.13%2.13B | 3.71%4.03B | 2.47%1.99B | -4.19%3.88B | -2.26%1.94B | 4.45%4.05B |
Employee expense | 6.93%-537M | 2.48%-1.14B | -1.41%-577M | -8.04%-1.17B | -8.59%-569M | -10.18%-1.08B | -8.49%-524M | 6.30%-982M | 3.59%-483M | -1.27%-1.05B |
Depreciation and amortization | 16.37%-378M | 4.81%-870M | 5.04%-452M | -1.90%-914M | -4.85%-476M | 1.97%-897M | -0.22%-454M | -0.11%-915M | -0.89%-453M | -25.99%-914M |
Revaluation surplus | ---- | 55.56%14M | 0.00%6M | -67.86%9M | -25.00%6M | 800.00%28M | 366.67%8M | -122.22%-4M | -113.64%-3M | -24.00%18M |
Special items of operating profit | 13.98%-203M | 12.47%-435M | 1.67%-236M | -9.96%-497M | -11.11%-240M | -6.86%-452M | 0.92%-216M | 18.50%-423M | 13.49%-218M | 22.34%-519M |
Operating profit | -32.72%693M | 0.34%1.77B | 20.47%1.03B | 8.68%1.77B | 6.08%855M | 4.17%1.62B | 2.41%806M | -1.95%1.56B | -2.72%787M | 7.78%1.59B |
Financing cost | 10.07%-125M | 0.74%-267M | -7.75%-139M | 0.37%-269M | 2.27%-129M | 8.78%-270M | 15.38%-132M | 13.20%-296M | 11.36%-156M | -1.17%-341M |
Share of profit from joint venture company | ---- | --1M | --1M | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
Earning before tax | -36.32%568M | 0.60%1.51B | 22.87%892M | 10.41%1.5B | 7.72%726M | 7.28%1.36B | 6.81%674M | 1.12%1.26B | -0.16%631M | 9.44%1.25B |
Tax | 38.61%-97M | 6.99%-253M | -17.04%-158M | -9.68%-272M | -5.47%-135M | -10.71%-248M | -14.29%-128M | 2.18%-224M | 0.88%-112M | -32.07%-229M |
After-tax profit from continuing operations | -35.83%471M | 2.29%1.25B | 24.20%734M | 10.57%1.22B | 8.24%591M | 6.54%1.11B | 5.20%546M | 1.86%1.04B | 0.00%519M | 5.38%1.02B |
Earning after tax | -35.83%471M | 2.29%1.25B | 24.20%734M | 10.57%1.22B | 8.24%591M | 6.54%1.11B | 5.20%546M | 1.86%1.04B | 0.00%519M | 5.38%1.02B |
Minority profit | 23.08%16M | -36.36%21M | -31.58%13M | 6.45%33M | 58.33%19M | 93.75%31M | 71.43%12M | -11.11%16M | -12.50%7M | 6.81%18M |
Profit attributable to shareholders | -36.89%455M | 3.36%1.23B | 26.05%721M | 10.69%1.19B | 7.12%572M | 5.18%1.08B | 4.30%534M | 2.10%1.02B | 0.20%512M | 5.36%1B |
Basic earnings per share | -36.92%0.123 | 3.10%0.333 | 25.81%0.195 | 10.24%0.323 | 6.90%0.155 | 5.02%0.293 | 3.57%0.145 | 1.45%0.279 | -0.71%0.14 | 3.00%0.275 |
Diluted earnings per share | -36.92%0.123 | 3.10%0.333 | 25.81%0.195 | 10.62%0.323 | 6.90%0.155 | 4.66%0.292 | 3.57%0.145 | 1.82%0.279 | -0.71%0.14 | 2.62%0.274 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data